Article
Risk factors for failure to complete a course of latent tuberculosis infection treatment in Salvador, Brazil.
Registro en:
MACHADO JUNIOR, A. et al. Risk factors for failure to complete a course of latent tuberculosis infection treatment in Salvador, Brazil.The International Journal of Tuberculosis and Lung Disease, v. 13, n. 6, p. 719-725, 2009.
1027-3719
Autor
Machado Junior, Almério
Finkmoore, Brook
Emodi, Krisztina
Takenami, Iukary Oliveira
Bessa, Theolis Costa Barbosa
Tavares, Maria Brandão
Reis, Mitermayer Galvão dos
Arruda, Sérgio Marcos
Riley, Lee Woodland
Resumen
BACKGROUND: Although treatment of latent tuberculosis infection (LTBI) is an essential component of tuberculosis (TB) control in countries such as the United States, it is not widely practiced in most TB-endemic countries. OBJECTIVE: To examine the practice of and adherence to LTBI treatment in a high-risk population in Brazil. DESIGN: We followed household contacts (HHCs) of patients hospitalized with pulmonary TB in Salvador, Brazil, for 6 months after they initiated LTBI treatment with isoniazid (INH). HHCs were asked to return to the hospital once a month for 6 months for follow-up visits and INH refills. RESULTS: Of 101 HHCs who initiated LTBI treatment, 54 (53.5%) completed the 6-month regimen. The risk of treatment non-completion was significantly higher in HHCs who reported side effects to INH (RR 2.69, 95%CI 1.3-5.8, P = 0.01), and in those who had to take two buses for a one-way trip to the hospital (RR 1.8, 95%CI 1.01-3.3, P = 0.04). Of the 101 HHCs, 29 (28.7%) did not return for any follow-up visits; these HHCs were significantly more likely to have a 2-bus commute to the hospital compared to HHCs who completed treatment (OR 20.69, 95%CI 2.1-208.4, P = 0.01). CONCLUSION: Nearly 50% of HHCs at high risk for developing TB completed a 6-month course of LTBI treatment. Completion of LTBI treatment was most affected by medication intolerance and commuting difficulties for follow-up visits.